A. L. Melikyan

Clinical and morphological features of different types of Castleman’s disease

A. L. Melikyan, Egorova Ek, А. М. Ковригина et al. · Terapevticheskii arkhiv · 2015 · 26 citations · Full text

Medicine, Hematology, Pathology +17

National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2020)

A. L. Melikyan, Irina N. Subortseva, Vasily Shuvaev et al. · Clinical oncohematology · 2021 · 26 citations · Full text

Medicine, Hematology, Internal Medicine +14

Sustained response off‐treatment in eltrombopag‐treated adult patients with <scp>ITP</scp> who are refractory or relapsed after first‐line steroids: Primary, final, and ad‐hoc analyses of the Phase <scp>II TAPER</scp> trial

Nichola Cooper, Waleed Ghanima, Nicola Vianelli et al. · American Journal of Hematology · 2023 · 23 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Biology of Myeloproliferative Malignancies

A. L. Melikyan, Irina N. Subortseva · Clinical oncohematology · 2016 · 19 citations · Full text

Medicine, Hematology, Molecular Biology +17

Clinical Characteristics of Cerebrovascular Pathology with Patients Suffering from Ph-Negative Myeloproliferative Disease

M. М. Tanashyan, Polina I. Kuznetsova, Anton A. Raskurazhev et al. · Cerebrovascular Diseases Extra · 2016 · 14 citations · Full text

Medicine, Hematology, Pathology +11